Mergers and Acquisitions Recap: Pfizer Deals to Nestle, Vodafone’s Growth Buy, AstraZeneca Active

And the winner in the baby food war is… Nestle, who (NSRGY.PK) gets Pfizer’s (NYSE:PFE) baby food business for $11.85 billion in cash. The acquisition will expand Nestle’s capacity to market infant formula in emerging markets, plus the potential to help it get back market share in China.

Vodafone (NASDAQ:VOD) snaps up Cable & Wireless Worldwide for £1.04 billion, or $1.7 billion, in cash. The deal will enable the former to offload soaring Internet traffic in the United Kingdom, to a larger capacity fixed network.

Don’t Miss: EMC May Have to Fight NetApp For This Deal.

The Illumina (NASDAQ:ILMN) vs. Roche (RHHBY.PK) drama comes to an end, as the latter drops it hostile takeover bid for the former, and is reported to be in conversations with the research centers of three large universities regaring the purchase of their gene sequencing technologies.

AstraZeneca (NYSE:AZN) acquires Ardea Biosciences (NASDAQ:RDEA), and is toying with the idea of purchasing other late-stage assets outside its research and development focus on cancer, diabetes and gastrointestinal ailments. Such moves would be to forestall and/or fight back against potential generic rivals.

Shares of the polymer products developer Landec (NASDAQ:LNDC) jump following word that it is purchasing GreenLine Foods for $63 million in cash with no assumed debt. A revenue guidance was issued to the effect.

ABB (NYSE:ABB) puts the kabosh on rumors that it might make an offer for Rockwell (NYSE:ROK). However, the company’s CEO confirmed that it is still thinking about filling restructuring gaps with (other) acquisitions.

Don’t Miss: AstraZeneca’s Big Drug Deal.